(Q33502054)

27 July 2017

title

Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets (English)

1 reference

27 July 2017

Jeske WP

1

1 reference

27 July 2017

Walenga JM

2

1 reference

27 July 2017

Szatkowski E

3

1 reference

27 July 2017

Ero M

4

1 reference

27 July 2017

Herbert JM

5

1 reference

27 July 2017

Haas S

6

1 reference

27 July 2017

Bakhos M

7

1 reference

27 July 2017

publication date

1 November 1997

1 reference

27 July 2017

1 reference

27 July 2017

volume

88

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

271-281

1 reference

Heparin-induced thrombocytopenia

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Studies on the frequency of heparin-associated thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Heparin-associated thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Fibrinogen, fibrinogen receptors, and the peptides that inhibit these interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Platelet glycoprotein IIb/IIIa receptor inhibitors in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Heparin‐induced thrombocytopenia: an improved method of detection based on lumi‐aggregometry

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Platelet microparticles bind, activate and aggregate neutrophils in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

The glycoprotein IIb/IIIa antagonist c7E3 inhibits platelet aggregation in the presence of heparin-associated antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

Platelet glycoprotein IIb/IIIa receptor inhibitors in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900254-5

7 January 2021

10.1016/S0049-3848(97)00254-5

Identifiers

DOI

1 reference

27 July 2017

1 reference